-
2
-
-
33750524856
-
The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world
-
Bennett DE: The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world. Curr Opin Infect Dis 2006;19:607-614.
-
(2006)
Curr Opin Infect Dis
, vol.19
, pp. 607-614
-
-
De, B.1
-
3
-
-
20844441971
-
Antiretroviral therapy in public and private routine health care clinics in Cameroon: Lessons from the Douala antiretroviral (DARVIR) initiative
-
DOI 10.1086/430712
-
Laurent C, Meilo H, Guiard-Schmid J-B, et al.: Antiretroviral therapy in public and private routine health care clinics in Cameroon: Lessons from the Douala Antiretroviral (DARVIR) Initiative. Clin Infect Dis 2005;41:108-111. (Pubitemid 40863752)
-
(2005)
Clinical Infectious Diseases
, vol.41
, Issue.1
, pp. 108-111
-
-
Laurent, C.1
Meilo, H.2
Guiard-Schmid, J.-B.3
Mapoure, Y.4
Noel, J.-M.5
M'Bangue, M.6
Joko, A.7
Rozenbaum, W.8
Ntone, F.N.9
Delaporte, E.10
-
4
-
-
38849123466
-
Human resources requirements for highly active antiretroviral therapy scale-up in Malawi
-
Muula AS, Chipeta J, Siziya S, Rudatsikira E, Mataya RH, and Kataika E: Human resources requirements for highly active antiretroviral therapy scale-up in Malawi. BMC Health Serv Res 2007;7:208.
-
(2007)
BMC Health Serv Res
, vol.7
, pp. 208
-
-
Muula, A.S.1
Chipeta, J.2
Siziya, S.3
Rudatsikira, E.4
Mataya, R.H.5
Kataika, E.6
-
5
-
-
72349088867
-
-
Prepared by Southern California Evidencebased Practice Center, Contract No. 290-02-0003.) AHRQ Publication No. 07-E014. Agency for Healthcare Research and Quality, Rockville MD
-
Shekelle P, Maglione M, Geotz MB, Wagner G, Wang Z, Hilton L, et al.: Antiretroviral (ARV) drug resistance in the developing world. Evidence Report/Technology Assessment No. 156. (Prepared by Southern California Evidencebased Practice Center, Contract No. 290-02-0003.) AHRQ Publication No. 07-E014. Agency for Healthcare Research and Quality, Rockville, MD, 2007.
-
(2007)
Antiretroviral (ARV) Drug Resistance in the Developing World. Evidence Report/Technology Assessment No. 156
-
-
Shekelle, P.1
Maglione, M.2
Geotz, M.B.3
Wagner, G.4
Wang, Z.5
Hilton, L.6
-
6
-
-
38449105585
-
Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda [letter to the editor]
-
Galluzzo CM, Germinario EAP, Bassani L, et al.: Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda [letter to the editor]. AIDS Res Hum Retroviruses 2007;23:1449-1451.
-
(2007)
AIDS Res Hum Retroviruses
, vol.23
, pp. 1449-1451
-
-
Galluzzo, C.M.1
Eap, G.2
Bassani, L.3
-
7
-
-
43249086528
-
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa
-
DOI 10.1086/587109
-
Marconi VC, Sunpath H, Lu Z, et al.: Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. Clin Infect Dis 2008;46:1589-1597. (Pubitemid 351706742)
-
(2008)
Clinical Infectious Diseases
, vol.46
, Issue.10
, pp. 1589-1597
-
-
Marconi, V.C.1
Sunpath, H.2
Lu, Z.3
Gordon, M.4
Koranteng-Apeagyei, K.5
Hampton, J.6
Carpenter, S.7
Giddy, J.8
Ross, D.9
Holst, H.10
Losina, E.11
Walker, B.D.12
Kuritzkes, D.R.13
-
8
-
-
33847169926
-
Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine
-
DOI 10.1097/QAI.0b013e31802b920e, PII 0012633420070201000004
-
Martinson NA, Morris L, Gray G, et al.: Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr 2007;44:148-153. (Pubitemid 46292216)
-
(2007)
Journal of Acquired Immune Deficiency Syndromes
, vol.44
, Issue.2
, pp. 148-153
-
-
Martinson, N.A.1
Morris, L.2
Gray, G.3
Moodley, D.4
Pillay, V.5
Cohen, S.6
Dhlamini, P.7
Puren, A.8
Bhayroo, S.9
Steyn, J.10
McIntyre, J.A.11
-
9
-
-
38149109662
-
Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: Evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B
-
Ndembi N, Abraha A, Pilch H, et al.: Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: Evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol 2008;46:177-184.
-
(2008)
J Clin Microbiol
, vol.46
, pp. 177-184
-
-
Ndembi, N.1
Abraha, A.2
Pilch, H.3
-
10
-
-
35348857692
-
HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Côte d'Ivoire: A 4-year survey, 2002-2006
-
DOI 10.1089/aid.2007.0072
-
Toni TD, Masquelier B, Minga A, et al.: HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Cô te d'Ivoire: A 4-year survey, 2002-2006. AIDS Res Hum Retroviruses 2007;23:1155-1160. (Pubitemid 47571940)
-
(2007)
AIDS Research and Human Retroviruses
, vol.23
, Issue.9
, pp. 1155-1160
-
-
Toni, T.D.1
Masquelier, B.2
Minga, A.3
Anglaret, X.4
Danel, C.5
Coulibaly, A.6
Chenal, H.7
Dabis, F.8
Salamon, R.9
Fleury, H.J.10
-
11
-
-
33846112661
-
Best-evidence interventions: Findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004
-
DOI 10.2105/AJPH.2005.076182
-
Lyles CM, Kay LS, Crepaz N, et al.: Best-evidence interventions: Findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004. Am J Public Health 2007;97:133-143. (Pubitemid 46067695)
-
(2007)
American Journal of Public Health
, vol.97
, Issue.1
, pp. 133-143
-
-
Lyles, C.M.1
Kay, L.S.2
Crepaz, N.3
Herbst, J.H.4
Passin, W.F.5
Kim, A.S.6
Rama, S.M.7
Thadiparthi, S.8
DeLuca, J.B.9
Mullins, M.M.10
-
12
-
-
35649018109
-
HIV risk perceptions and first sexual intercourse among youth in Cape Town, South Africa
-
Anderson KG, Beutel AM, and Maughan-Brown B: HIV risk perceptions and first sexual intercourse among youth in Cape Town, South Africa. Int Fam Plan Perspect 2007;33:98-105. (Pubitemid 350020557)
-
(2007)
International Family Planning Perspectives
, vol.33
, Issue.3
, pp. 98-105
-
-
Anderson, K.G.1
Beutel, A.M.2
Maughan-Brown, B.3
-
13
-
-
33750587775
-
Risky sexual behaviors of adolescents in rural Malawi: Evidence from focus groups
-
Dancy BL, Kaponda CPN, Kachingwe SI, and Norr KF: Risky sexual behaviors of adolescents in rural Malawi: Evidence from focus groups. J Natl Black Nurses Assoc 2006;17:22-28.
-
(2006)
J Natl Black Nurses Assoc
, vol.17
, pp. 22-28
-
-
Dancy, B.L.1
Cpn, K.2
Kachingwe, S.I.3
Norr, K.F.4
-
14
-
-
40949154387
-
Evidence-based efforts to prevent HIV infection: An overview of current status and future challenges
-
DOI 10.1086/522553
-
Holtgrave D: Evidence-based efforts to prevent HIV infection: An overview of current status and future challenges. Clin Infect Dis 2007;45:S293-S299. (Pubitemid 351417232)
-
(2007)
Clinical Infectious Diseases
, vol.45
, Issue.SUPPL. 4
-
-
Holtgrave, D.1
-
15
-
-
33645812933
-
What works, and what remains to be done, in HIV prevention in the United States
-
Holtgrave DR and Curran JW: What works, and what remains to be done, in HIV prevention in the United States. Annu Rev Public Health 2006;27:261-275.
-
(2006)
Annu Rev Public Health
, vol.27
, pp. 261-275
-
-
Holtgrave, D.R.1
Curran, J.W.2
-
16
-
-
39749127343
-
"Bundling" HIV prevention: Integrating services to promote synergistic gain
-
DOI 10.1016/j.ypmed.2007.09.006, PII S0091743507004161
-
Ickovics JR: "Bundling" HIV prevention: Integrating services to promote synergistic gain. Prev Med 2008;46:222-225. (Pubitemid 351308148)
-
(2008)
Preventive Medicine
, vol.46
, Issue.3
, pp. 222-225
-
-
Ickovics, J.R.1
-
17
-
-
23944492639
-
From treatment to prevention: The interplay between HIV/AIDS treatment availability and HIV/AIDS prevention programming in Khayelitsha, South Africa
-
DOI 10.1093/jurban/jti090
-
Levy NC, Miksad RA, and Fein OT: From treatment to prevention: The interplay between HIV/AIDS treatment availability and HIV/AIDS prevention programming in Khayelitsha, South Africa. J Urban Health 2005;82:498-509. (Pubitemid 41191568)
-
(2005)
Journal of Urban Health
, vol.82
, Issue.3
, pp. 498-509
-
-
Levy, N.C.1
Miksad, R.A.2
Fein, O.T.3
-
18
-
-
40549102749
-
Sexual behavior and reproductive health among HIV-infected patients in urban and rural South Africa
-
DOI 10.1097/QAI.0b013e3181648de8
-
Lurie M, Pronyk P, de Moor E, et al.: Sexual behavior and reproductive health among HIV-infected patients in urban and rural South Africa. J Acquir Immune Defic Syndr 2008;47:484-493. (Pubitemid 351366965)
-
(2008)
Journal of Acquired Immune Deficiency Syndromes
, vol.47
, Issue.4
, pp. 484-493
-
-
Lurie, M.1
Pronyk, P.2
De Moor, E.3
Heyer, A.4
De Bruyn, G.5
Struthers, H.6
McIntyre, J.7
Gray, G.8
Marinda, E.9
Klipstein-Grobusch, K.10
Martinson, N.11
-
19
-
-
34548606827
-
Skinning the goat and pulling the load: Transactional sex among youth in Dar es Salaam, Tanzania
-
DOI 10.1080/09540120701294286, PII 781959796
-
Maganja RK, Maman S, Groves A, and Mbwambo JK: Skinning the goat and pulling the load: Transactional sex among youth in Dar es Salaam, Tanzania. AIDS Care 2007; 19:974-981. (Pubitemid 47402887)
-
(2007)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
, vol.19
, Issue.8
, pp. 974-981
-
-
Maganja, R.K.1
Maman, S.2
Groues, A.3
Mbwambo, J.K.4
-
20
-
-
34548357053
-
The dynamics of intergenerational sexual relationships: The experience of schoolgirls in Botswana
-
DOI 10.1071/SH06070
-
Nkosana J and Rosenthal D: The dynamics of intergeneraltional sexual relationships: The experience of schoolgirls in Botswana. Sex Health 2007;4:181-187. (Pubitemid 47339636)
-
(2007)
Sexual Health
, vol.4
, Issue.3
, pp. 181-187
-
-
Nkosana, J.1
Rosenthal, D.2
-
21
-
-
33947631339
-
Modelling the public health impact of male circumcision for HIV prevention in high prevalence area in Africa
-
Nagelkerke NJD, Moses S, de Vlas SJ, and Bailey RC: Modelling the public health impact of male circumcision for HIV prevention in high prevalence area in Africa. BMC Infect Dis 2007;7:16.
-
(2007)
BMC Infect Dis
, vol.7
, pp. 16
-
-
Njd, N.1
Moses, S.2
De Vlas, S.J.3
Bailey, R.C.4
-
22
-
-
33846018595
-
Circumcision and HIV transmission
-
DOI 10.1097/QCO.0b013e328012c5bc, PII 0000143220070200000007
-
Quinn TC: Circumcision and HIV transmission. Curr Opin Infect Dis 2007;20:33-38. (Pubitemid 46052124)
-
(2007)
Current Opinion in Infectious Diseases
, vol.20
, Issue.1
, pp. 33-38
-
-
Quinn, T.C.1
-
23
-
-
34248191210
-
The Future of HIV Prevention: Control of Sexually Transmitted Infections and Circumcision Interventions
-
DOI 10.1016/j.idc.2007.03.005, PII S0891552007000189
-
Sahasrabuddhe VV and Vermund SH: The future of HIV prevention: Control of sexually transmitted infections and circumcision interventions. Infect Dis Clin North Am 2007;21:241-257. (Pubitemid 46719805)
-
(2007)
Infectious Disease Clinics of North America
, vol.21
, Issue.1
, pp. 241-257
-
-
Sahasrabuddhe, V.V.1
Vermund, S.H.2
-
24
-
-
33746456905
-
The potential impact of male circumcision on HIV in sub-Saharan Africa
-
DOI 10.1371/journal.pmed.0030262
-
Williams BG, Lloyd-Smith JO, Gouws E, et al.: The potential impact of male circumcision on HIV in sub-Saharan Africa. PLoS Med 2006;3:1032-1040. (Pubitemid 44125989)
-
(2006)
PLoS Medicine
, vol.3
, Issue.7
, pp. 1032-1040
-
-
Williams, B.G.1
Lloyd-Smith, J.O.2
Gouws, E.3
Hankins, C.4
Getz, W.M.5
Hargrove, J.6
De Zoysa, I.7
Dye, C.8
Auvert, B.9
-
25
-
-
33847151707
-
Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial
-
DOI 10.1016/S0140-6736(07)60312-2, PII S0140673607603122
-
Bailey RC, Moses S, Parker CB, et al.: Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 2007;369:643-656. (Pubitemid 46281312)
-
(2007)
Lancet
, vol.369
, Issue.9562
, pp. 643-656
-
-
Bailey, R.C.1
Moses, S.2
Parker, C.B.3
Agot, K.4
Maclean, I.5
Krieger, J.N.6
Williams, C.F.7
Campbell, R.T.8
Ndinya-Achola, J.O.9
-
26
-
-
33847104829
-
Male circumcision for HIV prevention in men in Rakai Uganda: A randomised trial
-
Gray RH, Kigozi G, Serwadda D, et al.: Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet 2007;369:657-666.
-
(2007)
Lancet
, vol.369
, pp. 657-666
-
-
Gray, R.H.1
Kigozi, G.2
Serwadda, D.3
-
27
-
-
77955930318
-
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women
-
Karim Q, Karim S, Frohlich J, et al.: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-1174.
-
(2010)
Science
, vol.329
, pp. 1168-1174
-
-
Karim, Q.1
Karim, S.2
Frohlich, J.3
-
28
-
-
33749019447
-
Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa
-
DOI 10.1097/01.qai.0000230526.79341.83, PII 0012633420061001000013
-
Amirfar S, Hollenberg JP, and Abdool Karim SS: Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa. J Acquir Immune Defic Syndr 2006;43:219-225. (Pubitemid 44454817)
-
(2006)
Journal of Acquired Immune Deficiency Syndromes
, vol.43
, Issue.2
, pp. 219-225
-
-
Amirfar, S.1
Hollenberg, J.P.2
Abdool Karim, S.S.3
-
29
-
-
34848910202
-
Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example
-
DOI 10.1097/QAI.0b013e31812506fd, PII 0012633420070901000012
-
Andersson KM, Owens DK, Vardas E, Gray GE, McIntyre JA, and Paltiel AD: Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example. J Acquir Immune Defic Syndr 2007;46:78-90. (Pubitemid 47507437)
-
(2007)
Journal of Acquired Immune Deficiency Syndromes
, vol.46
, Issue.1
, pp. 78-90
-
-
Andersson, K.M.1
Owens, D.K.2
Vardas, E.3
Gray, G.E.4
McIntyre, J.A.5
Paltiel, A.D.6
-
30
-
-
22144441378
-
Predicting the potential public health impact by disease-modifying HIV vaccines in South Africa: The problem of subtypes
-
DOI 10.2174/1568005054201616
-
Blower SM, Bodine EN, and Grovit-Ferbas K: Predicting the potential public health impact of disease-modifying HIV vaccines in South Africa: The problem of subtypes. Curr Drug Targets 2005;5:179-192. (Pubitemid 40974797)
-
(2005)
Current Drug Targets - Infectious Disorders
, vol.5
, Issue.2
, pp. 179-192
-
-
Blower, S.M.1
Bodine, E.N.2
Grovit-Ferbas, K.3
-
31
-
-
4043060710
-
Correlates of immune protection in HIV-1 infection: What we know, what we don't know, what we should know
-
DOI 10.1038/nm0804-806
-
Pantaleo G and Koup RA: Correlates of immune protection in HIV-1 infection: What we know, what we don't know, what we should know. Nat Med 2004;10:806-810. (Pubitemid 39070851)
-
(2004)
Nature Medicine
, vol.10
, Issue.8
, pp. 806-810
-
-
Pantaleo, G.1
Koup, R.A.2
-
32
-
-
11144357869
-
Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection
-
DOI 10.1084/jem.20031982
-
Draenert R, Le Gall S, Pfafferott KJ, et al.: Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med 2004; 199:905-915. (Pubitemid 38481082)
-
(2004)
Journal of Experimental Medicine
, vol.199
, Issue.7
, pp. 905-915
-
-
Draenert, R.1
Le Gall, S.2
Pfafferott, K.J.3
Leslie, A.J.4
Chetty, P.5
Brander, C.6
Holmes, E.C.7
Chang, S.-C.8
Feeney, M.E.9
Addo, M.M.10
Ruiz, L.11
Ramduth, D.12
Jeena, P.13
Altfeld, M.14
Thomas, S.15
Tang, Y.16
Verrill, C.L.17
Dixon, C.18
Prado, J.G.19
Kiepiela, P.20
Martinez-Picado, J.21
Walker, B.D.22
Goulder, P.J.R.23
more..
-
33
-
-
9144259999
-
Impaired Processing and Presentation of Cytotoxic-T-Lymphocyte (CTL) Epitopes Are Major Escape Mechanisms from CTL Immune Pressure in Human Immunodeficiency Virus Type 1 Infection
-
DOI 10.1128/JVI.78.3.1324-1332.2004
-
Yokomaku Y, Miura H, Tomiyama H, et al.: Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 Infection. J Virol 2004;78:1324-1332. (Pubitemid 38095842)
-
(2004)
Journal of Virology
, vol.78
, Issue.3
, pp. 1324-1332
-
-
Yokomaku, Y.1
Miura, H.2
Tomiyama, H.3
Kawana-Tachikawa, A.4
Takiguchi, M.5
Kojima, A.6
Nagai, Y.7
Iwamoto, A.8
Matsuda, Z.9
Ariyoshi, K.10
-
34
-
-
27144513224
-
+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution
-
DOI 10.1128/JVI.79.21.13239-13249.2005
-
Allen TM, Altfeld M, Geer SC, et al.: Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 2005;79:13239-13249. (Pubitemid 41508139)
-
(2005)
Journal of Virology
, vol.79
, Issue.21
, pp. 13239-13249
-
-
Allen, T.M.1
Altfeld, M.2
Geer, S.C.3
Kalife, E.T.4
Moore, C.5
O'Sullivan, K.M.6
DeSouza, I.7
Feeney, M.E.8
Eldridge, R.L.9
Maier, E.L.10
Kaufmann, D.E.11
Lahaie, M.P.12
Reyor, L.13
Tanzi, G.14
Johnston, M.N.15
Brander, C.16
Draenert, R.17
Rockstroh, J.K.18
Jessen, H.19
Rosenberg, E.S.20
Mallal, S.A.21
Walker, B.D.22
more..
-
35
-
-
20444426834
-
A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1
-
DOI 10.1089/aid.2005.21.395
-
Ammaranond P, Zaunders J, Satchell C, Van Bockel D, Cooper DA, and Kelleher AD: A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1. AIDS Res Hum Retroviruses 2005;21:395-397. (Pubitemid 40800455)
-
(2005)
AIDS Research and Human Retroviruses
, vol.21
, Issue.5
, pp. 395-397
-
-
Ammaranond, P.1
Zaunders, J.2
Satchell, C.3
Van Bockel, D.4
Cooper, D.A.5
Kelleher, A.D.6
-
36
-
-
24644516542
-
Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection
-
DOI 10.1128/JVI.79.18.12100-12105.2005
-
Pillay T, Zhang H-T, Drijfhout JW, et al.: Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection. J Virol 2005;79: 12100-12105. (Pubitemid 41279328)
-
(2005)
Journal of Virology
, vol.79
, Issue.18
, pp. 12100-12105
-
-
Pillay, T.1
Zhang, H.-T.2
Drijfhout, J.W.3
Robinson, N.4
Brown, H.5
Khan, M.6
Moodley, J.7
Adhikari, M.8
Pfafferott, K.9
Feeney, M.E.10
St. John, A.11
Holmes, E.C.12
Coovadia, H.M.13
Klenerman, P.14
Goulder, P.J.R.15
Phillips, R.E.16
-
37
-
-
34249339797
-
Cornering HIV: Taking advantage of interactions between selective pressures
-
DOI 10.1016/j.mehy.2006.12.012, PII S0306987706009145
-
Á vila-Ríos S, Reyes-Terán G, and Espinosa E: Cornering HIV: Taking advantage of interactions between selective pressures. Med Hypotheses 2007;69:422-431. (Pubitemid 46818696)
-
(2007)
Medical Hypotheses
, vol.69
, Issue.2
, pp. 422-431
-
-
Avila-Rios, S.1
Reyes-Teran, G.2
Espinosa, E.3
-
38
-
-
13944277994
-
Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys
-
DOI 10.1128/JVI.79.5.2956-2963.2005
-
Seaman MS, Xu L, Beaudry K, et al.: Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys. J Virol 2005;79:2956-2963. (Pubitemid 40270574)
-
(2005)
Journal of Virology
, vol.79
, Issue.5
, pp. 2956-2963
-
-
Seaman, M.S.1
Xu, L.2
Beaudry, K.3
Martin, K.L.4
Beddall, M.H.5
Miura, A.6
Sambor, A.7
Chakrabarti, B.K.8
Huang, Y.9
Bailer, R.10
Koup, R.A.11
Mascola, J.R.12
Nabel, G.J.13
Letvin, N.L.14
-
39
-
-
0036319711
-
Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy
-
DOI 10.1016/S1473-3099(02)00343-2
-
Thomson MM, Pérez-Á varez L, Ná jera R: Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002; 2:461-471. (Pubitemid 34826851)
-
(2002)
Lancet Infectious Diseases
, vol.2
, Issue.8
, pp. 461-471
-
-
Thomson, M.M.1
Perez-Alvarez, L.2
Najera, R.3
-
40
-
-
0031763875
-
Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development
-
van der Groen G, Nyambi PN, Beirnaert E, et al.: Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development. AIDS Res Hum Retroviruses 1998; 14:S-211-S-221. (Pubitemid 28513476)
-
(1998)
AIDS Research and Human Retroviruses
, vol.14
, Issue.SUPPL. 3
-
-
Van Der Groen, G.1
Nyambi, P.N.2
Beirnaert, E.3
Davis, D.4
Fransen, K.5
Heyndrickx, L.6
Ondoa, P.7
Van Der Auwera, G.8
Janssens, W.9
-
41
-
-
13944254982
-
Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
-
The rgp120 HIV Vaccine Study Group
-
The rgp120 HIV Vaccine Study Group: Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis 2005;191:654-665.
-
(2005)
J Infect Dis
, vol.191
, pp. 654-665
-
-
-
42
-
-
33845433434
-
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
-
DOI 10.1086/508748
-
Pitisuttithum P, Gilbert P, Gurwith M, et al.: Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 2006; 194:1661-1671. (Pubitemid 44901996)
-
(2006)
Journal of Infectious Diseases
, vol.194
, Issue.12
, pp. 1661-1671
-
-
Pitisuttithum, P.1
Gilbert, P.2
Gurwith, M.3
Heyward, W.4
Martin, M.5
Van Griensven, F.6
Hu, D.7
Tappero, J.W.8
Choopanya, K.9
-
43
-
-
0031037693
-
Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers
-
DOI 10.1073/pnas.94.4.1396
-
Ferrari G, Humphrey W, McElrath MJ, et al.: Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci USA 1997;94:1396-1401. (Pubitemid 27087862)
-
(1997)
Proceedings of the National Academy of Sciences of the United States of America
, vol.94
, Issue.4
, pp. 1396-1401
-
-
Ferrari, G.1
Humphrey, W.2
Mcelrath, M.J.3
Excler, J.-L.4
Duliege, A.-M.5
Clements, M.L.6
Corey, L.C.7
Bolognesi, D.P.8
Weinhold, K.J.9
-
44
-
-
18344418549
-
Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children
-
DOI 10.1006/viro.1998.9373
-
Buseyne F, Chaix ML, Fleury B, et al.: Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children. Virology 1998;250:316-324. (Pubitemid 28489631)
-
(1998)
Virology
, vol.250
, Issue.2
, pp. 316-324
-
-
Buseyne, F.1
Chaix, M.L.2
Fleury, B.3
Manigard, O.4
Burgard, M.5
Blanche, S.6
Rouzioux, C.7
Riviere, Y.8
-
45
-
-
0034692516
-
Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines
-
Ferrari G, Kostyu DD, Cox J, et al.: Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines. AIDS Res Hum Retroviruses 2000;16:1433-1443.
-
(2000)
AIDS Res Hum Retroviruses
, vol.16
, pp. 1433-1443
-
-
Ferrari, G.1
Kostyu, D.D.2
Cox, J.3
-
46
-
-
0037192588
-
Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients
-
DOI 10.1097/00002030-200203290-00005
-
Fukada K, Tomiyama H, Wasi C, et al.: Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients. AIDS 2002; 16:701-711. (Pubitemid 34274460)
-
(2002)
AIDS
, vol.16
, Issue.5
, pp. 701-711
-
-
Fukada, K.1
Tomiyama, H.2
Wasi, C.3
Matsuda, T.4
Kusagawa, S.5
Sato, H.6
Oka, S.7
Takebe, Y.8
Takiguchi, M.9
-
47
-
-
0031686770
-
Cross-clade cytotoxic t cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais
-
Lynch JA, deSouza M, Robb MD, et al.: Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais. J Infect Dis 1998;178:1040-1046. (Pubitemid 28452196)
-
(1998)
Journal of Infectious Diseases
, vol.178
, Issue.4
, pp. 1040-1046
-
-
Lynch, J.A.1
Desouza, M.2
Robb, M.D.3
Markowitz, L.4
Nitayaphan, S.5
Sapan, C.V.6
Mann, D.L.7
Birx, D.L.8
Cox, J.H.9
-
48
-
-
0032551608
-
+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection
-
Wilson SE, Pedersen SL, Kunich JC, et al.: Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res Hum Retroviruses 1998;14:925-937. (Pubitemid 28337481)
-
(1998)
AIDS Research and Human Retroviruses
, vol.14
, Issue.11
, pp. 925-937
-
-
Wilson, S.E.1
Pedersen, S.L.2
Kunich, J.C.3
Wilkins, V.L.4
Mann, D.L.5
Mazzara, G.P.6
Tartaglia, J.7
Celum, C.L.8
Sheppard, H.W.9
-
49
-
-
20244369447
-
Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents
-
DOI 10.1086/428450
-
Coplan PM, Gupta SB, Dubey SA, et al.: Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis 2005;191:1427-1434. (Pubitemid 40563353)
-
(2005)
Journal of Infectious Diseases
, vol.191
, Issue.9
, pp. 1427-1434
-
-
Coplan, P.M.1
Gupta, S.B.2
Dubey, S.A.3
Pitisuttithum, P.4
Nikas, A.5
Mbewe, B.6
Vardas, E.7
Schechter, M.8
Kallas, E.G.9
Freed, D.C.10
Fu, T.-M.11
Mast, C.T.12
Puthavathana, P.13
Kublin, J.14
Collins, K.B.15
Chisi, J.16
Pendame, R.17
Thaler, S.J.18
Gray, G.19
Mcintyre, J.20
Straus, W.L.21
Condra, J.H.22
Mehrotra, D.V.23
Guess, H.A.24
Emini, E.A.25
Shiver, J.W.26
more..
-
50
-
-
0037791747
-
Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys
-
DOI 10.1128/JVI.77.13.7367-7375.2003
-
Barouch DH, Kunstman J, Glowczwskie J, et al.: Viral escape from dominant simian immunodeficiency virus epitopespecific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. J Virol 2003;77:7367-7375. (Pubitemid 36734505)
-
(2003)
Journal of Virology
, vol.77
, Issue.13
, pp. 7367-7375
-
-
Barouch, D.H.1
Kunstman, J.2
Glowczwskie, J.3
Kunstman, K.J.4
Egan, M.A.5
Peyerl, F.W.6
Santra, S.7
Kuroda, M.J.8
Schmitz, J.E.9
Beaudry, K.10
Krivulka, G.R.11
Lifton, M.A.12
Gorgone, D.A.13
Wolinsky, S.M.14
Letvin, N.L.15
-
51
-
-
0035025623
-
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus ankara vaccination
-
DOI 10.1128/JVI.75.11.5151-5158.2001
-
Barouch DH, Santra S, Kuroda MJ, et al.: Reduction of simian- human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination. J Virol 2001;75:5151-5158. (Pubitemid 32448537)
-
(2001)
Journal of Virology
, vol.75
, Issue.11
, pp. 5151-5158
-
-
Barouch, D.H.1
Santra, S.2
Kuroda, M.J.3
Schmitz, J.E.4
Plishka, R.5
Buckler-White, A.6
Gaitan, A.E.7
Zin, R.8
Nam, J.-H.9
Wyatt, L.S.10
Lifton, M.A.11
Nickerson, C.E.12
Moss, B.13
Montefiori, D.C.14
Hirsch, V.M.15
Letvin, N.L.16
-
52
-
-
0035341521
-
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers
-
DOI 10.1086/319863
-
Belshe RB, Stevens C, Gorse GJ, et al.: Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers. J Infect Dis 2001; 183:1343-1352. (Pubitemid 32337116)
-
(2001)
Journal of Infectious Diseases
, vol.183
, Issue.9
, pp. 1343-1352
-
-
Belshe, R.B.1
Stevens, C.2
Gorse, G.J.3
Buchbinder, S.4
Weinhold, K.5
Sheppard, H.6
Stablein, D.7
Self, S.8
McNamara, J.9
Frey, S.10
Flores, J.11
Excler, J.L.12
Klein, M.13
El Habib, R.14
Duliege, A.-M.15
Harro, C.16
Corey, L.17
Keefer, M.18
Mulligan, M.19
Wright, P.20
Celum, C.21
Judson, F.22
Mayer, K.23
McKirnan, D.24
Marmor, M.25
Woody, G.26
more..
-
53
-
-
0033496071
-
+ cytotoxic T lymphocyte responses in seronegative volunteers
-
DOI 10.1086/314895
-
Evans TG, Keefer MC, Weinhold KJ, et al.: A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. J Infect Dis 1999; 180:290-298. (Pubitemid 30256308)
-
(1999)
Journal of Infectious Diseases
, vol.180
, Issue.2
, pp. 290-298
-
-
Evans, T.G.1
Keefer, M.C.2
Weinhold, K.J.3
Wolff, M.4
Montefiori, D.5
Gorse, G.J.6
Graham, B.S.7
McElrath, M.J.8
Clements-Mann, M.L.9
Mulligan, M.J.10
Fast, P.11
Walker, M.C.12
Excler, J.-L.13
Duliege, A.-M.14
Tartaglia, J.15
-
54
-
-
0033394054
-
Efficient human immunodeficiency virus (HIV)-1 Gag-Env pseudovirion formation elicited from mammalian cells by a canarypox HIV vaccine candidate
-
DOI 10.1086/315028
-
Fang Z-Y, Kuli-Zade I, and Spearman P: Efficient human immunodeficiency virus (HIV)-1 gag-env pseudovirion formation elicited from mammalian cells by a canarypox HIV vaccine candidate. J Infect Dis 1999;180:1122-1132. (Pubitemid 30070195)
-
(1999)
Journal of Infectious Diseases
, vol.180
, Issue.4
, pp. 1122-1132
-
-
Fang, Z.-Y.1
Kuli-Zade, I.2
Spearman, P.3
-
55
-
-
19244362119
-
Memory cytotoxic t lymphocyte responses in human immunodeficiency virus type 1 (HIV-1) - Negative volunteers immunized with a recombinant canarypox expressing gp160 of HIV-1 and boosted with a recombinant gp160
-
Fleury B, Janvier G, Pialoux G, et al.: Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp160 of HIV-1 and boosted with a recombinant gp160. J Infect Dis 1996;174: 734-738. (Pubitemid 26325888)
-
(1996)
Journal of Infectious Diseases
, vol.174
, Issue.4
, pp. 734-738
-
-
Fleury, B.1
Janvier, G.2
Pialoux, G.3
Buseyne, F.4
Robertson, M.N.5
Tartaglia, J.6
Paoletti, E.7
Kieny, M.P.8
Excler, J.L.9
Riviere, Y.10
-
56
-
-
25444525193
-
High-dose recombinant canarypox vaccine expressing HIV-1 protein, in seronegative human subjects
-
DOI 10.1086/432915
-
Goepfert PA, Horton H, McElrath MJ, et al.: High-dose recombinant canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. J Infect Dis 2005;192: 1249-1259. (Pubitemid 41368426)
-
(2005)
Journal of Infectious Diseases
, vol.192
, Issue.7
, pp. 1249-1259
-
-
Goepfert, P.A.1
Horton, H.2
McElrath, M.J.3
Gurunathan, S.4
Ferrari, G.5
Tomaras, G.D.6
Montefiori, D.C.7
Allen, M.8
Chiu, Y.-L.9
Spearman, P.10
Fuchs, J.D.11
Koblin, B.A.12
Blattner, W.A.13
Frey, S.14
Keefer, M.C.15
Baden, L.R.16
Corey, L.17
-
57
-
-
0036500532
-
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS vaccine evaluation group protocol 022A
-
Gupta K, Hudgens M, Corey L, et al.: Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS vaccine evaluation group protocol 022A. J Acquir Immune Defic Syndr 2002;29:254-261. (Pubitemid 34208533)
-
(2002)
Journal of Acquired Immune Deficiency Syndromes
, vol.29
, Issue.3
, pp. 254-261
-
-
Gupta, K.1
Hudgens, M.2
Corey, L.3
McElrath, M.J.4
Weinhold, K.5
Montefiori, D.C.6
Gorse, G.J.7
Frey, S.E.8
Keefer, M.C.9
Evans, T.G.10
Dolin, R.11
Schwartz, D.H.12
Harro, C.13
Graham, B.14
Spearman, P.W.15
Mulligan, M.16
Goepfert, P.17
-
58
-
-
0032815843
-
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus ankara boost vaccination regimen
-
Hanke T, Samuel RV, Blanchard TJ, et al.: Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vacccinia virus Ankara boost vaccination regimen. J Virol 1999;73:7524-7532. (Pubitemid 29383236)
-
(1999)
Journal of Virology
, vol.73
, Issue.9
, pp. 7524-7532
-
-
Hanke, T.1
Samuel, R.V.2
Blanchard, T.J.3
Neumann, V.C.4
Allen, T.M.5
Boyson, J.E.6
Sharpe, S.A.7
Cook, N.8
Smith, G.L.9
Watkins, D.I.10
Cranage, M.P.11
McMichael, A.J.12
-
59
-
-
0036839574
-
+ T cell responses
-
Hel Z, Nacsa J, Tryniszewska E, et al.: Containment of simian immunodeficiency virus infection in vaccinated macaques: Correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses. J Immunol 2002;169:4778-4787. (Pubitemid 35217140)
-
(2002)
Journal of Immunology
, vol.169
, Issue.9
, pp. 4778-4787
-
-
Hel, Z.1
Nacsa, J.2
Tryniszewska, E.3
Tsai, W.-P.4
Parks, R.W.5
Montefiori, D.C.6
Felber, B.K.7
Tartaglia, J.8
Pavlakis, G.N.9
Franchini, G.10
-
60
-
-
0035892889
-
+ T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen
-
Hel Z, Tsai WP, Thornton A., et al.: Potentiation of simian immunodeficiency virus (SIV)-specific CD4+ and CD8+ T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen. J Immunol 2001;167:7180-7191. (Pubitemid 33144216)
-
(2001)
Journal of Immunology
, vol.167
, Issue.12
, pp. 7180-7191
-
-
Hel, Z.1
Tsai, W.-P.2
Thornton, A.3
Nacsa, J.4
Giuliani, L.5
Tryniszewska, E.6
Poudyal, M.7
Venzon, D.8
Wang, X.9
Altman, J.10
Watkins, D.I.11
Lu, W.12
Von Gegerfelt, A.13
Felber, B.K.14
Tartaglia, J.15
Pavlakis, G.N.16
Franchini, G.17
-
61
-
-
0025793169
-
+ cytotoxic T lymphocytes
-
Shen L, Chen ZW, Miller MD, et al.: Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes. Science 1991;252:440-443. (Pubitemid 21916982)
-
(1991)
Science
, vol.252
, Issue.5004
, pp. 440-443
-
-
Shen, L.1
Chen, Z.W.2
Miller, M.D.3
Stallard, V.4
Mazzara, G.P.5
Panicali, D.L.6
Letvin, N.L.7
-
62
-
-
33845439080
-
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector
-
DOI 10.1086/509258
-
Catanzaro AT, Koup RA, Roederer M, et al.: Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J Infect Dis 2006;194:1638-1649. (Pubitemid 44901994)
-
(2006)
Journal of Infectious Diseases
, vol.194
, Issue.12
, pp. 1638-1649
-
-
Catanzaro, A.T.1
Koup, R.A.2
Roederer, M.3
Bailer, R.T.4
Enama, M.E.5
Moodie, Z.6
Gu, L.7
Martin, J.E.8
Novik, L.9
Chakrabarti, B.K.10
Butman, B.T.11
Gall, J.G.D.12
King, C.R.13
Andrews, C.A.14
Sheets, R.15
Gomez, P.L.16
Mascola, J.R.17
Nabel, G.J.18
Graham, B.S.19
Larkin, B.20
McCluskey, M.21
Hubka, S.22
Holman, L.23
Gordon, I.24
Edmonds, P.25
Rucker, S.26
Parrino, J.27
Casazza, J.28
Fix, A.29
more..
-
63
-
-
29244455769
-
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
-
DOI 10.1128/JVI.79.24.15547-15555.2005
-
Casimiro DR, Wang F, Schleif WA, et al.: Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing gag. J Virol 2005;79: 15547-15555. (Pubitemid 43032336)
-
(2005)
Journal of Virology
, vol.79
, Issue.24
, pp. 15547-15555
-
-
Casimiro, D.R.1
Wang, F.2
Schleif, W.A.3
Liang, X.4
Zhang, Z.-Q.5
Tobery, T.W.6
Davies, M.-E.7
McDermott, A.B.8
O'Connor, D.H.9
Fridman, A.10
Bagchi, A.11
Tussey, L.G.12
Bett, A.J.13
Finnefrock, A.C.14
Fu, T.-M.15
Tang, A.16
Wilson, K.A.17
Chen, M.18
Perry, H.C.19
Heidecker, G.J.20
Freed, D.C.21
Carella, A.22
Punt, K.S.23
Sykes, K.J.24
Huang, L.25
Ausensi, V.I.26
Bachinsky, M.27
Sadasivan-Nair, U.28
Watkins, D.I.29
Emini, E.A.30
Shiver, J.W.31
more..
-
64
-
-
0038664390
-
Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene
-
DOI 10.1128/JVI.77.11.6305-6313.2003
-
Casimiro DR, Chen L, Fu T-M, et al.: Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J Virol 2003;77:6305-6313. (Pubitemid 36588400)
-
(2003)
Journal of Virology
, vol.77
, Issue.11
, pp. 6305-6313
-
-
Casimiro, D.R.1
Chen, L.2
Fu, T.-M.3
Evans, R.K.4
Caulfield, M.J.5
Davies, M.-E.6
Tang, A.7
Chen, M.8
Huang, L.9
Harris, V.10
Freed, D.C.11
Wilson, K.A.12
Dubey, S.13
Zhu, D.-M.14
Nawrocki, D.15
Mach, H.16
Troutman, R.17
Isopi, L.18
Williams, D.19
Hurni, W.20
Xu, Z.21
Smith, J.G.22
Wang, S.23
Liu, X.24
Guan, L.25
Long, R.26
Trigona, W.27
Heidecker, G.J.28
Perry, H.C.29
Persaud, N.30
Toner, T.J.31
Su, Q.32
Liang, X.33
Youil, R.34
Chastain, M.35
Bett, A.J.36
Volkin, D.B.37
Emini, E.A.38
Shiver, J.W.39
more..
-
65
-
-
0037122719
-
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
-
DOI 10.1038/415331a
-
Shiver JW, Fu T-M, Chen L, et al.: Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency- virus immunity [letter]. Nature 2002;415:331-335. (Pubitemid 34087555)
-
(2002)
Nature
, vol.415
, Issue.6869
, pp. 331-335
-
-
Shiver, J.W.1
Fu, T.-M.2
Chen, L.3
Casimiro, D.R.4
Davies, M.-E.5
Evans, R.K.6
Zhang, Z.-Q.7
Simon, A.J.8
Trigona, W.L.9
Dubey, S.A.10
Huang, L.11
Harris, V.A.12
Long, R.S.13
Liang, X.14
Handt, L.15
Schleif, W.A.16
Zhu, L.17
Freed, D.C.18
Persaud, N.V.19
Guan, L.20
Punt, K.S.21
Tang, A.22
Chen, M.23
Wilson, K.A.24
Collins, K.B.25
Heidecker, G.J.26
Fernandez, V.R.27
Perry, H.C.28
Joyce, J.G.29
Grimm, K.M.30
Cook, J.C.31
Keller, P.M.32
Kresock, D.S.33
Mach, H.34
Troutman, R.D.35
Isopi, L.A.36
Williams, D.M.37
Xu, Z.38
Bohannon, K.E.39
Volkin, D.B.40
Montefiori, D.C.41
Miura, A.42
Krivulka, G.R.43
Lifton, M.A.44
Kuroda, M.J.45
Schmitz, J.E.46
Letvin, N.L.47
Caulfield, M.J.48
Bett, A.J.49
Youil, R.50
Kaslow, D.C.51
Emini, E.A.52
more..
-
66
-
-
20944444088
-
Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates
-
DOI 10.1128/JVI.79.10.6516-6522.2005
-
Santra S, Seaman MS, Xu L, et al.: Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates. J Virol 2005;79:6516-6522. (Pubitemid 40617255)
-
(2005)
Journal of Virology
, vol.79
, Issue.10
, pp. 6516-6522
-
-
Santra, S.1
Seaman, M.S.2
Xu, L.3
Barouch, D.H.4
Lord, C.I.5
Lifton, M.A.6
Gorgone, D.A.7
Beaudry, K.R.8
Svehla, K.9
Welcher, B.10
Chakrabarti, B.K.11
Huang, Y.12
Yang, Z.-Y.13
Mascola, J.R.14
Nabel, G.J.15
Letvin, N.L.16
-
67
-
-
42049115708
-
Efficacy results from the STEP Study (Merck V520 Protocol 023/HVTN 502): A phase II test-of-concept trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent Vaccine
-
Abstract 88LB
-
Robertson M, Mehrotra D, Fitzgerald D, et al.: Efficacy results from the STEP Study (Merck V520 Protocol 023/HVTN 502): A phase II test-of-concept trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent Vaccine. 15th Conference on Retroviruses and Opportunistic Infections 2008. Abstract 88LB.
-
(2008)
15th Conference on Retroviruses and Opportunistic Infections
-
-
Robertson, M.1
Mehrotra, D.2
Fitzgerald, D.3
-
68
-
-
56649105122
-
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebocontrolled, test-of-concept trial
-
Buchbinder SP, Mehrotra DV, Duerr A, et al.: Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebocontrolled, test-of-concept trial. Lancet 2008;372:1881-1893.
-
(2008)
Lancet
, vol.372
, pp. 1881-1893
-
-
Buchbinder, S.P.1
Mehrotra, D.V.2
Duerr, A.3
-
69
-
-
73349094086
-
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
-
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al.: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009;361:2209-2220.
-
(2009)
N Engl J Med
, vol.361
, pp. 2209-2220
-
-
Rerks-Ngarm, S.1
Pitisuttithum, P.2
Nitayaphan, S.3
-
70
-
-
77954920017
-
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
-
Wu X, Yang ZY, Liang Y, et al.: Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 2010;329(5993):856-861.
-
(2010)
Science
, vol.329
, Issue.5993
, pp. 856-861
-
-
Wu, X.1
Yang, Z.Y.2
Liang, Y.3
-
71
-
-
60549106905
-
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults
-
Harro CD, Robertson MN, Lally MA, et al.: Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults. AIDS Res Hum Retroviruses 2009;25:1-12.
-
(2009)
AIDS Res Hum Retroviruses
, vol.25
, pp. 1-12
-
-
Harro, C.D.1
Robertson, M.N.2
Ma, L.3
-
72
-
-
34247635041
-
Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay
-
DOI 10.1097/QAI.0b013e3180377b5b
-
Dubey S, Clair J, Fu T-M, et al.: Detection of HIV vaccineinduced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay. J Acquir Immune Defic Syndr 2007;45:20-27. (Pubitemid 46684439)
-
(2007)
Journal of Acquired Immune Deficiency Syndromes
, vol.45
, Issue.1
, pp. 20-27
-
-
Dubey, S.1
Clair, J.2
Fu, T.-M.3
Guan, L.4
Long, R.5
Mogg, R.6
Anderson, K.7
Collins, K.B.8
Gaunt, C.9
Fernandez, V.R.10
Zhu, L.11
Kierstead, L.12
Thaler, S.13
Gupta, S.B.14
Straus, W.15
Mehrotra, D.16
Tobery, T.W.17
Casimiro, D.R.18
Shiver, J.W.19
-
73
-
-
33846813761
-
Enhanced rates and magnitude of immune responses detected against an HIV vaccine: Effect of using an optimized process for isolating PBMC
-
DOI 10.1089/aid.2006.0129
-
Kierstead LS, Dubey S, Meyer B, et al.: Enhanced rates and magnitude of immune responses detected against an HIV vaccine: Effect of using an optimized process for isolating PBMC. AIDS Res Hum Retroviruses 2007;23:86-92. (Pubitemid 46214176)
-
(2007)
AIDS Research and Human Retroviruses
, vol.23
, Issue.1
, pp. 86-92
-
-
Kierstead, L.S.1
Dubey, S.2
Meyer, B.3
Tobery, T.W.4
Mogg, R.5
Fernandez, V.R.6
Long, R.7
Guan, L.8
Gaunt, C.9
Collins, K.10
Sykes, K.J.11
Mehrotra, D.V.12
Chirmule, N.13
Shiver, J.W.14
Casimiro, D.R.15
-
74
-
-
12144291311
-
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: Application in epidemiologic studies and in the design of adenovector vaccines
-
DOI 10.1089/104303404322886147
-
Aste-Amézaga M, Bett AJ, Wang F, et al.: Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: Application in epidemiologic studies in the design of adenovector vaccines. Hum Gene Ther 2004;15:293-304. (Pubitemid 38365918)
-
(2004)
Human Gene Therapy
, vol.15
, Issue.3
, pp. 293-304
-
-
Aste-Amezaga, M.1
Bett, A.J.2
Wang, F.3
Casimiro, D.R.4
Antonello, J.M.5
Patel, D.K.6
Dell, E.C.7
Franlin, L.L.8
Dougherty, N.M.9
Bennett, P.S.10
Perry, H.C.11
Davies, M.-E.12
Shiver, J.W.13
Keller, P.M.14
Yeager, M.D.15
-
76
-
-
2942527313
-
Use of the false discovery rate for evaluating clinical safety data
-
Mehrotra DV and Heyse JF: Use of the false discovery rate for evaluating clinical safety data. Stat Methods Med Res 2004;13:227-238. (Pubitemid 38744605)
-
(2004)
Statistical Methods in Medical Research
, vol.13
, Issue.3
, pp. 227-238
-
-
Mehrotra, D.V.1
Heyse, J.F.2
-
77
-
-
0006582115
-
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
-
DOI 10.1038/nm0496-405
-
Kaslow RA, Carrington M, Apple R, et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2: 405-411. (Pubitemid 26193012)
-
(1996)
Nature Medicine
, vol.2
, Issue.4
, pp. 405-411
-
-
Kaslow, R.A.1
Carrington, M.2
Apple, R.3
Park, L.4
Munoz, A.5
Saah, A.J.6
Goedert, J.J.7
Winkler, C.8
O'Brien, S.J.9
Rinaldo, C.10
Detels, R.11
Blattner, W.12
Phair, J.13
Erlich, H.14
Mann, D.L.15
-
78
-
-
56749096265
-
HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine
-
Quirk EK, Mogg R, Brown DD, et al.: HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine. Clin Infect Dis 2008;47:1593-1599.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 1593-1599
-
-
Quirk, E.K.1
Mogg, R.2
Brown, D.D.3
|